Looking Into Insulet’s Recent Short Interest
Insulet’s (NYSE:PODD) short percent of float has fallen 29.73% since its last report. The company recently reported that…
Where Insulet Stands With Analysts
In the last three months, 6 analysts have published ratings on Insulet (NASDAQ:PODD), offering a diverse range of…
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news.
Will Insulet’s Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future.
Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What’s Driving Markets Tuesday?
Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What’s Driving Markets Friday?
A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures.
Insulet Expects Q2 Revenue Growth Of 15%-18%; Raising Its Expected Revenue Growth From 12%-17% To 14%-18%
2024 Outlook:Revenue Guidance (in constant currency):For the year ending December 31, 2024, the Company is raising its expected revenue growth to a range of 14% to 18% (previously 12% to 17%). Revenue growth ranges by
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
4 Analysts Assess Insulet: What You Need To Know
During the last three months, 4 analysts shared their evaluations of Insulet (NASDAQ:PODD), revealing diverse outlooks from bullish…
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.